跳至主要内容
临床试验/RBR-6hnmxv
RBR-6hnmxv进行中(未招募)未知

Dermatological assessment of primary dermal irritability accumulated and sensitization.

Ipclin - Pesquisa Clínica Integrada0 个研究点开始时间: 2019年10月10日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 65Y(—)

入选标准

  • Full skin in the study region (back); Age 18 to 65 years; Gender; male or female, Participants with phototypes I; II; III and IV (according to Fitzpatrick's classification); Absence of irritation allergy history to the material used in the study; Have signed the Term of Free and Informed Consent (TCLE); Participants who want to participate in the study without financial gain. They will only be reimbursed for transportation and food expenses.

排除标准

  • Participants who refuse to participate in the study in question; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions (pigmentation disorders; vascular malformations; scarring; increased hairiness; ephelides and nevus in large quantities; sunburn); Dermatoses (local and disseminated) that could interfere with the results of the study; Pregnant women or infants; History of allergic reactions; irritation or intense discomfort feelings to topical products; for health and medicines; Volunteers with a history of allergy to the material used in the study; History of atopy; History of conditions aggravated or triggered by ultraviolet radiation; Immunodeficiency carriers; Kidney; cardiac or hepatic transplanted patients; Intense sun exposure or tanning session up to 15 days prior to initial evaluation; Forecast of intense sun exposure or session of bron during the course of the study; Forecast of bathing; pool or sauna during the study; Participants practicing aquatic sports;
  • Use of the following topical systemic medicinal products; immunosuppressive; antihistaminic; non-hormonal anti-inflammatory drugs; and corticosteroids up to two weeks prior to selection; Treatment with acid vitamin A and or its derivatives via oral or topical use up to 01 month before start of the study; Vaccination prediction during the study or up to 03 weeks before the study; Any condition not mentioned above that in the opinion of the investigator could compromise the evaluation of the study.

研究者

发起方
Ipclin - Pesquisa Clínica Integrada

相似试验

Assessment of skin irritability. | 临床试验